2 TSX Marijuana Stocks That Have Gotten Extremely Cheap

Thanks to negative publicity, shares in CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) have gotten very cheap.

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

It’s been a tough summer for the marijuana industry, with Horizons Medical Marijuana Life Sciences ETF falling 11.5% so far since June. Although the selloff in marijuana stocks as a whole has been pronounced, some have been hit harder than others, with CannTrust Holdings (TSX:TRST)(NYSE:CTST) down 57% year to date. Reasons given for the sector-wide selloff include disappointing earnings reports from major producers and increasing regulatory scrutiny on the industry.

While the weed selloff has hit many investors hard, it has also made certain marijuana stocks cheaper than ever before. In particular, some weed stocks that have come under scrutiny are now trading at price-to-book value multiples that are within the realm of sanity. The following are two that you can scoop up right now for cheaper than most other weed stocks.

Aphria

Aphria (TSX:APHA)(NYSE:APHA) is Canada’s third-largest weed producer by revenue. Its stock is down 11.7% this year, despite some incredible growth results, and may be undervalued by some metrics.

In its most recent quarter, Aphria grew its revenue by 617% and its gross profit by 101%. Although net income came in at a massive $108 million loss, it was influenced by non-cash factors, including a $9 million loss on the fair value of biological assets. The operating loss was much smaller at $89 million.

With a price-to-book ratio of 1.03 as of this writing, Aphria is extremely cheap for a marijuana stock.

CannTrust 

Through its short history, CannTrust has been one of the more profitable TSX marijuana stocks, posting positive net and operating income. In its second-most-recent quarter, it posted net income of $6.8 million and operating income of $9.2 million. More recently, those figures swung to losses after CannTrust began investing more heavily in growth. However, it’s still undeniable that CannTrust has historically been one of the more profitable marijuana producers.

Recently, TRST shares started tumbling after it was revealed that Health Canada had put a hold on CannTrust’s inventory due to unlicensed growing. The company admitted to its error and has committed to improved regulatory compliance going forward.

Health Canada’s hold on CannTrust’s inventory amounted to 5,000 kg in total. The company is still able to produce marijuana and will be able to sell weed that did not originate from the unlicensed rooms that triggered the regulatory clampdown.

Assuming that no further Health Canada drama is forthcoming, CannTrust should bounce back from its current woes. That’s no guarantee, but if the current issues are smoothed out, then CannTrust could eventually prove to have been a bargain at current prices. With a price-to-sales ratio of 7.02 and an estimated forward P/E of 15, it’s easily the cheapest TSX marijuana stock right now. Just keep in mind that this stock has gotten cheap for a good reason, and there could be more pain ahead.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »